Drug Shortage Report for ABILIFY
Report ID | 141232 |
Drug Identification Number | 02322404 |
Brand name | ABILIFY |
Common or Proper name | Abilify |
Company Name | OTSUKA PHARMACEUTICAL CO LTD |
Market Status | MARKETED |
Active Ingredient(s) | ARIPIPRAZOLE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | bottle format |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2021-08-16 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-10-12 |
Shortage status | Resolved |
Updated date | 2021-10-13 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-10-13 | English | Compare |
v5 | 2021-10-12 | French | Compare |
v4 | 2021-10-12 | English | Compare |
v3 | 2021-08-17 | English | Compare |
v2 | 2021-06-18 | French | Compare |
v1 | 2021-06-18 | English | Compare |
Showing 1 to 6 of 6